SCHEMBL8867391

SCHEMBL8867391

O=C(O)c1cccc2ncc(C3CCCCC3)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.51
KDM4E B2RXH2 1/20 0.50
GLA P06280 1/20 0.50
HTT P42858 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KMO O15229 1/20 0.48
ACMSD Q8TDX5 2/20 0.47
CAMKK2 Q96RR4 5/20 0.46
CAMKK1 Q8N5S9 4/20 0.46
POLB P06746 1/20 0.42
PSMB5 P28074 1/20 0.41
KDM5A P29375 1/20 0.40
KDM5B Q9UGL1 1/20 0.40
EGLN1 Q9GZT9 3/20 0.40
TBK1 Q9UHD2 2/20 0.40
SERPINE1 P05121 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9411557 0.81 KDM4E (0.44) DHODHKDM4EGLAHTTKMT2A
SCHEMBL11819344 0.77 ACMSD (0.56) DHODHKDM4EGLAHTTKMT2A
SCHEMBL11820122 0.77 ACMSD (0.56) DHODHKDM4EGLAHTTKMT2A
SCHEMBL11816217 0.77 ACMSD (0.56) DHODHKDM4EGLAHTTKMT2A
SCHEMBL8867889 0.77 PSMB5 (0.45) DHODHKDM4EGLAHTTKMT2A
SCHEMBL8867753 0.77 TLR7 (0.42) DHODHKDM4EGLAHTTKMT2A
SCHEMBL11813461 0.76 ACMSD (0.51) DHODHKDM4EGLAHTTKMT2A
SCHEMBL9766384 0.76 ACMSD (0.57) DHODHKDM4EGLAHTTKMT2A
SCHEMBL11815948 0.76 ACMSD (0.55) DHODHKDM4EGLAHTTKMT2A
SCHEMBL28140597 0.75 DHODH (0.47) DHODHKMT2ASMN1; SMN2TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629320-A INOTROPIC AGENTS, HYPOTENSIVE AGENTS, OTHER CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1997-05-13 US disclosed
US-5550245-A INTERMEDIATES FOR AGENTS USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1996-08-27 US disclosed
US-5504210-A TREATMENT FOR CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1996-04-02 US disclosed
CN-1100419-A 3-quinolyl-substituted dihydropyridines, process for their preparation and their use in medicaments BAYER AG (DE) 1995-03-22 CN disclosed
EP-0627427-A1 3-Quinolyl substituted dihydropyridines, process for their preparation and their use in drugs BAYER AG (DE) 1994-12-07 EP disclosed